Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F7WYK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,178
Award facts
- Contract value 100% obligated
- $28,178.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $28.2K firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 30, 2026, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This is a non-set-aside, competitively awarded contract with an ultimate completion date of February 2, 2026, and performance to be executed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.9M through December 2026), which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in delivering brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to defense and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition, with delivery orders typically featuring firm fixed pricing and covering medications ranging from diabetes treatments to specialized therapeutics. This award represents a routine task order fulfilling military medical supply needs through the established prime vendor relationship with DLA.
Quick answers
Who was awarded contract SPE2DR26F7WYK?
SPE2DR26F7WYK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F7WYK worth?
The government has obligated $28,178 on SPE2DR26F7WYK.
Is contract SPE2DR26F7WYK an order under another contract?
Yes. SPE2DR26F7WYK is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WYK competed?
The extent of competition for SPE2DR26F7WYK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award